SPP1 and urinary bladder carcinoma: This work also highlights the importance of allocating additional priority to characterize SPP1 isoforms in cancer concomitantly with clinical research to validate the prognostic value of SPP1 and its potential therapeutic target in bladder cancer in a larger patient cohort and multi-institutional networks.